Clinical review demonstrates multiorgan impacts and therapeutic challenges in IgG4-related disease, highlighting the need for targeted alternatives beyond glucocorticoids.
IgG4-related disease is an increasingly recognized fibroinflammatory condition with protean manifestations. The disorder is characterized by inflammatory mass lesions that can involve many different organs and organ systems — including the pancreas and biliary tract, orbital structures, salivary and lacrimal glands, lungs, retroperitoneum, and kidneys — and can also cause aortitis and periaortitis. 1 The effects of the disease relate to resultant damage in the affected organ systems. It often can be a relapsing disorder, and the optimal approach to inducing or maintaining remission has not been well defined. The etiologic factors of IgG4-related disease are uncertain, but the histopathological characteristics . . .
No takes yet. Share an insight, caveat, or question.
Robert Spiera (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: